Tandem Diabetes Care. has filed a patent for an ambulatory infusion pump with a touchscreen that automatically locks during uninterrupted operations to prevent inadvertent activation. The processor receives touch input indicating uninterrupted operation, locks the touchscreen, and unlocks it after completion. GlobalData’s report on Tandem Diabetes Care gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Tandem Diabetes Care Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Tandem Diabetes Care, Wearable drug delivery devices was a key innovation area identified from patents. Tandem Diabetes Care's grant share as of January 2024 was 48%. Grant share is based on the ratio of number of grants to total number of patents.

Touchscreen lock feature for ambulatory infusion pump

Source: United States Patent and Trademark Office (USPTO). Credit: Tandem Diabetes Care Inc

The patent application (Publication Number: US20240038380A1) describes an ambulatory infusion pump with innovative features. The pump includes a housing, a delivery mechanism for fluid delivery, a user interface with a touchscreen, and a processor for generating menu screens and processing touch input. One unique aspect is the automatic locking of the touchscreen during uninterrupted operations, preventing accidental input. The touchscreen is unlocked only upon receiving a predefined unlock touch input, ensuring user control and safety during critical pump operations such as cartridge replacement or fluid filling.

Additionally, the system can include an infusion cartridge with a reservoir and outlet for fluid delivery, coupled with the pump device. The processor in the cartridge or pump generates menu screens and handles touch input for setting parameters. The touchscreen locking feature during uninterrupted operations adds an extra layer of security and prevents errors. The processor's ability to display an unlock confirmation screen further enhances user interaction and ensures that the pump does not navigate to subsequent menu screens until a confirmation touch input is received, maintaining a user-friendly and safe operation of the ambulatory infusion system.

To know more about GlobalData’s detailed insights on Tandem Diabetes Care, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies